miraDry
miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis.[1] It was approved by the United States Food and Drug Administration (FDA) in 2011 and was also approved in Europe.[1] miraDry selectively destroys axillary sweat glands without affecting the superficial layers of the skin.[1] In addition to sweat glands, miraDry destroys hair follicles in the axillary region regardless of hair color.[1] It is about 72.5 to 90% effective[2] and sweat is reduced by about 82% on average.[3] It also reduces axillary hair by about 75%.[4] The effects of miraDry are noticeable almost immediately and are long-lasting or permanent.[1] A case of death due to miraDry caused by necrotizing fasciitis that was complicated by streptococcal toxic shock syndrome has been reported.[5][6]
References
[edit]- ^ a b c d e Gupta AK, Venkataraman M, Joshi LT, Cooper EA (November 2022). "Potential use of microwave technology in dermatology". J Dermatolog Treat. 33 (7): 2899–2910. doi:10.1080/09546634.2022.2089333. hdl:10026.1/19307. PMID 35699665.
- ^ Arora G, Kassir M, Patil A, Sadeghi P, Gold MH, Adatto M, Grabbe S, Goldust M (January 2022). "Treatment of Axillary hyperhidrosis". J Cosmet Dermatol. 21 (1): 62–70. doi:10.1111/jocd.14378. PMID 34416078.
- ^ Jacob C (March 2013). "Treatment of hyperhidrosis with microwave technology". Semin Cutan Med Surg. 32 (1): 2–8. PMID 24049923.
- ^ https://corp.miradry.com/wp-content/uploads/2023/03/LB0322.D-MD4000-MC-User-Manual-freshConnect.pdf
- ^ Stam R (March 2024). "New developments in cosmetic applications of electromagnetic fields: Client and occupational hazard assessment". Bioelectromagnetics. doi:10.1002/bem.22503. PMID 38533721.
- ^ Wen S, Unuma K, Makino Y, Mori H, Uemura K (September 2022). "Fatal consequence after MiraDry® treatment: Necrotizing fasciitis complicated with streptococcal toxic shock syndrome". Leg Med (Tokyo). 58: 102095. doi:10.1016/j.legalmed.2022.102095. PMID 35662070.